Isaac George discusses the one-year clinical results of the novel polymeric leaflet TRIA valve for patients undergoing surgical mitral valve replacement.

Suzanne Baron and David Elison discuss when to intervene in cases of asymptomatic aortic stenosis based on the complete patient profile. 

Brian Lindman, Rahul Sharma, and Sreek Vemulapalli share the benefits of using artificial intelligence tools to assist in identifying patients with aortic stenosis.

Brian Lindman, Sammy Elmariah, and David Wood explain how echocardiogram alerts are assisting in the management and evaluation of aortic stenosis patients.

Bernard Prendergast and Jordan Strom discuss the evolution of AS referral and how earlier treatment impacts patient outcomes. 

Philippe Généreux, Brad Oldemeyer, and Jennifer Daniel share their experiences treating asymptomatic aortic stenosis patients in the EARLY TAVR trial.

Michael Mack speaks to Allan Schwartz, a principal investigator of the EARLY TAVR trial, who explains how it informs patient management.

Bernard Prendergast and Philippe Généreux detail the EARLY TAVR trial design and outcomes.

Juan Granada and Pierre Elias discuss how AI is an essential tool for improving screening access and increasing early diagnosis of valvular heart disease.

Juan Granada and Brian Lindman share insights on tools and data that can be used to achieve earlier diagnosis and intervention in valvular heart disease.